Translational Sciences Competitors and Similar CompaniesClear all

Chinook Therapeutics's competitors and similar companies include Mesoblast.
Chinook Therapeutics
Chinook Therapeutics
Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
Mesoblast
Mesoblast
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
Founding Date
Founding Date
2011
Founding Date
2004
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Melbourne, AU HQ
Singapore, SG
New York, US
Employees
Employees
27
Employees
73

Financial

Revenue (est.)
Revenue (est.)
$6.1m (FY, 2022)
Revenue (est.)
$17.2m (FY, 2025)
Net income
Net income
($187.9m) (FY, 2022)
Net income
($102.1m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 171m
Total funding raised
$ 56.2m
For sources of this data, please see the company profile

View Company Profiles

Mesoblast
HQ
Melbourne, AU
Employees
73

Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.

View company